Givaudan Boosts Investment in Cosmetic Actives


Following its acquisitions of Soliance and Induchem, Givaudan has invested CHF 11 million in a new active cosmetic ingredients fermentation line in Pomacle, France.

As the company notes, "This investment is aligned with Givaudan’s 2020 ambition to become a significant player in the ACI space."

Gilles Andrier, CEO of Givaudan, said, “Givaudan acquired Soliance in June 2014 to grow its ACI business and followed this with the acquisition of Induchem in August 2015. The extension of this production line is another example of our commitment to ACI and to our local and global customers who have a growing interest in cosmetics.”

More in Regulatory